Medinet Co., Ltd. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medinet Co., Ltd. with three other
companies in this sector in Japan:
Carna Biosciences Inc
sales of 1.57 billion Japanese Yen [US$15.14 million]
of which 61%
was Drug Discovery Support Business),
Symbio Pharmaceuticals Ltd
(1.93 billion Japanese Yen [US$18.66 million]
of which 100%
was Auxiliary Business), and
(1.91 billion Japanese Yen [US$18.43 million]
of which 54%
was Cell Therapy Technology Development Busi).
Medinet Co., Ltd. reported sales of ¥1.67 billion (US$16.16 million)
September of 2015.
decrease of 9.2%
versus 2014, when the company's sales were ¥1.84 billion.
Contributing to the drop in overall sales was the 9.5% decline
in Cell Processing, from ¥1.84 billion to ¥1.67 billion.
However, these declines were partially offset by the increase in sales of
Cell Therapy Products Business (up 178.4% to ¥8.36 million)